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QT dispersion was originally proposed to measure spatial dispersion of ventricular recovery
times. Later, it was shown that QT dispersion does not directly reflect the dispersion of
recovery times and that it results mainly from variations in the T loop morphology and the
error of QT measurement. The reliability of both automatic and manual measurement of QT
dispersion is low and significantly lower than that of the QT interval. The measurement error
is of the order of the differences between different patient groups. The agreement between
automatic and manual measurement is poor. There is little to choose between various QT
dispersion indices, as well as between different lead systems for their measurement. Reported
values of QT dispersion vary widely, e.g., normal values from 10 to 71 ms. Although QT
dispersion is increased in cardiac patients compared with healthy subjects and prognostic
value of QT dispersion has been reported, values are largely overlapping, both between
healthy subjects and cardiac patients and between patients with and without adverse outcome.
In reality, QT dispersion is a crude and approximate measure of abnormality of the complete
course of repolarization. Probably only grossly abnormal values (e.g. $100 ms), outside the
range of measurement error may potentially have practical value by pointing to a grossly
abnormal repolarization. Efforts should be directed toward established as well as new methods
for assessment and quantification of repolarization abnormalities, such as principal compo-
nent analysis of the T wave, T loop descriptors, and T wave morphology and wavefront
direction descriptors. (J Am Coll Cardiol 2000;36:1749–66) © 2000 by the American
College of Cardiology
Attempts to characterize the abnormalities of ventricular
repolarization from the surface electrocardiogram (ECG)
have a long history. Precise mathematical approaches can be
traced back to the 1960s (1). For clinical purposes, however,
the ECG based assessment of ventricular repolarization has
traditionally been limited to the measurement of the QT
interval and to the description of the polarity and shape of
the T wave often using vague terms such as “nonspecific ST
segment and T wave changes.”
In 1990, a report by the group of the late Professor
Campbell revived an old idea of the interlead differences in
the QT interval duration. The range of the durations,
termed “QT dispersion,” was proposed as an index of the
spatial dispersion of the ventricular recovery times (2). It
was proposed that the different ECG leads magnify the
ECG signal of different myocardial regions and that, con-
sequently, QT dispersion is an almost direct measure of the
heterogeneity of myocardial repolarization. The cardiolog-
ical community welcomed the idea. The methodological
simplicity and the promise of solving the old and much
debated problem of regional information within the stan-
dard ECG were appealing.
Since the first publication, the cardiological literature has
been flooded by articles reporting QT dispersion in practi-
cally every cardiac as well as many noncardiac syndromes
and diseases. However, voices of concern about the validity
of the concept and the methodology of the measurement
were raised repeatedly. Today, after a decade of the “QT
dispersion era,” some conclusions may be drawn from the
wide spectrum of opinions ranging from sheer enthusiastic
approval to verdicts of ‘the greatest fallacy in electrocardi-
ography in the 1990s (3).
PATHOPHYSIOLOGY OF QT DISPERSION
The initial concept of QT dispersion seemed to be based on
a sound logic. The link between the dispersion of ventricular
recovery times and arrhythmias had been demonstrated
repeatedly (4–6). It was also believed that the standard
surface ECG contains regional information. Therefore,
finding increased QT dispersion in patient groups in whom
the heterogeneity of the ventricular recovery times was
previously established, it was assumed that QT dispersion is
a reflection of the dispersion of ventricular recovery times.
The validity of the concept seemed to be further consoli-
dated by studies correlating intracardiac monophasic action
potentials (MAPs) with various QT dispersion indices.
Higham et al. (7) recorded epicardial MAPs during
cardiac surgery and measured directly the dispersion of
recovery times as well as surface QT dispersion during sinus
rhythm and during ventricular pacing. They found a high
positive correlation between the MAPs and ECG disper-
sion indices. Later, using a custom-built rabbit heart setup
with simultaneous recording of MAP and 12-lead ECGs,
Zabel et al. (8) showed that the dispersions of the QT and
JT intervals were significantly correlated with the dispersion
of 90% duration of the action potential duration (ADP90)
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and with the dispersion of recovery times. The same authors
also confirmed this in patients with 12-lead ECGs recorded
within 24 h of the MAPs (9). These studies were generally
interpreted as a proof of QT dispersion representing re-
gional variations in the duration of the ventricular action
potentials.
Serious arguments against this concept originated from
the electrocardiographic lead theory. If the majority of the
information about the ventricular electrical activity is con-
tained in the spatial QRS and T loops, the major reason for
the differences between separate leads has to be the loss of
information from the projection of the loop into the
separate leads (10). Two original studies published in 1998
supported this idea.
Macfarlane et al. (11) and Lee et al. (12) showed
independently that QT dispersion can also be found in the
so-called derived 12-lead ECGs, i.e., ECGs reconstructed
from the XYZ leads, which naturally contain no regional
information. In both studies the QT dispersion in the
originally recorded and in the “derived” 12-leads was sur-
prisingly similar (29.1 6 10.2 vs. 27.5 6 10.8 ms and 41 6
18 vs. 40 6 20 ms, respectively).
Kors et al. (13) further contributed to the understanding
of the interlead differences. They found that QT dispersion
was significantly different between patients with narrow
(54.2 6 27.1 ms) and wide T loops (69.5 6 33.5 ms, p ,
0.001). They also showed that in each of the six limb as well
as the six precordial leads, the difference between the QT
interval in a lead and the maximum QT interval was
dependent on the angle between the axis of the lead and the
axis of the terminal part of the T loop.
Punske et al. (14) compared the spatial distribution of the
QT intervals from high-resolution maps on (a) human body
surface, (b) the surface of a tank containing an isolated
canine heart, and (c) the surface of exposed canine hearts,
with the potential distributions on cardiac and body sur-
faces, and with recovery times on cardiac surfaces. They
showed that on the body and tank surface, as well as on the
epicardium, the “zero potential line” (no potential difference
relative to a reference electrode) stabilizes for 10 to 30 ms at
the end of repolarization. This stabilization of the zero line
in a given location leads to isoelectric terminal portions of
the T wave for leads in the vicinity. Regions of shortest QT
intervals always coincided with the location of the zero line.
In addition, there were no consistent regions of earliest
recovery times on the cardiac surface that coincided with the
location of the zero potential line or shortest QT intervals.
These studies showed convincingly that the interlead dif-
ferences of the QT intervals are a reflection of (and could be
quantified from) the morphology of the T wave loop.
Most recently, Malik et al. (15) proposed a new ECG
processing technique to distinguish the T wave signals
representing the three-dimensional movement of the ECG
dipole from the nondipolar components likely to be related
to regional heterogeneity of myocardial repolarization. Al-
though the nondipolar components differed among the
clinical groups, there was very little correlation between the
relative amount of the nondipolar components and QT
dispersion measured in the same ECGs (r 5 20.046,
0.2805, 20.1531, and 0.0771, in normal subjects, HCM
patients, DCM patients, and survivors of acute MI, respec-
tively, p 5 0.03 for HCM, others NS).
Hence, it is reasonable to conclude that the dispersions of
ventricular recovery times measured with MAPs and QT
dispersion are direct and indirect expressions of repolariza-
tion abnormalities that are likely to correlate even without
any mechanistic link. General abnormalities of ventricular
repolarization, not only those leading to regional dispersion
of recovery times, modify the spatial T wave loop. As a
result of any abnormality, projections of the loop into the
individual ECG leads may become less normal and the
terminal points of the T wave in the ECG tracings become
more difficult to be localized. The effect of local dispersion
of repolarization on the morphology of the T wave loop
explains the (indirect) link between MAP recordings and
QT dispersion. Thus, T wave loop dynamics and the
variable projections of the loop into individual ECG leads
seem to be the true mechanistic background of QT disper-
sion.
The studies of the link between the T loop morphology
and QT dispersion also confirmed what was empirically
known long ago: the more abnormal the T wave morphol-
ogy in separate leads, the more difficult and unreliable the
localization of the T wave offset in each lead and, conse-
quently, the greater the likelihood of an increased QT
dispersion. As Kors et al. (13) demonstrated, variations of
the T loop morphology lead to variations in the practically
unmeasurable final part of the T wave, i.e., the proportion of
the signal falling within the noise band (Fig. 1). Thus,
variations of the T loop morphology may lead to both true
variations in the length of the projections of the T loop onto
the separate leads and to an increased measurement error
(Fig. 2).
It is now clear that QT dispersion is merely a crude and
indirect measure of general repolarization abnormalities.
Thus, the original hypothesis linking QT interval duration
in separate ECG leads to repolarization duration in separate
myocardial regions was ill founded. At the same time,
disproving this hypothesis is not a good reason for stating
that “QT dispersion does not exist.” QT dispersion is clearly
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only a very approximate and rather simplistic expression of
repolarization abnormalities that suffers from a poor patho-
physiologic concept as well as, as shown in the next section,
from methodological difficulties. However, regardless of the
crudeness of the expression, abnormalities of the repolar-
ization are of significant importance (16,17). Even very
indirect and very approximate measures of T wave loop
abnormalities may still have some, though restricted, infor-
mative value. Consequently, it would not be appropriate to
dismiss all the numerous observations made with QT
dispersion just because the original pathophysiological con-
cept was flawed. Rather, all the previous observations should
be reevaluated with an insight into the limitations of the
concept and the shortcomings of the technique.
MEASUREMENT OF QT DISPERSION
It has been known for decades that manual determination of
the T wave offset is very unreliable (18). Unfortunately,
available automatic methods have not proven their superi-
ority. The main sources of error, both for human observers
and computers, are low T wave amplitude (19,20) and
merges of T waves with U and/or P waves. The morphology
of the T wave also strongly influences QT interval measure-
ment.
Several basic algorithms for automatic determination
of the T wave end are available (Fig. 3). The threshold
methods localize the T offset as an intercept of the T wave
or of its derivative with a threshold above the isoelectric line,
usually expressed as a percentage of the T wave amplitude.
The slope methods determine the T offset as an intercept
between the slope of the descending part of the T wave and
the isoelectric line, or a threshold line above it. The slope
can be the steepest tangent computed by various line fitting
algorithms or a straight line through the inflex point and the
peak of the T wave. Obviously, the measured values of the
QT interval depend on the shape of the descending part of
the T wave (Fig. 4). The amplitude of the T wave strongly
influences the reliability of both automatic (19,21) and
manual (20) measurement.
U wave. The origin of the U wave remains disputed. The
theories that attributed the U wave to the delayed repolar-
ization of the His-Purkinje fibers (22) or to mechanoelec-
trical mechanism (23) were superseded by the M-cell theory
by Antzelevich et al. (24). However, later experiments by
the same group showed that what is often interpreted as a
“pathologically augmented U wave” or “T-U complex” is in
fact a prolonged biphasic T wave with an interrupted
ascending or descending limb (25). Manual measurement is
even less reliable for certain T-U patterns, e.g., when the T
wave is flat or inverted and the U wave augmented.
Repolarization patterns of complex morphology are fre-
quently classified differently by different observers, leading
to substantial variability of the measurement (26).
Probably, electrophysiological mechanisms responsible
for usual “physiologic” U wave are different from those
leading to abnormal gross U waves, for instance those seen
in congenital and acquired long-QT syndrome. In our view,
Figure 2. QT dispersion as a result of both different real duration and
different measurable duration of QT intervals. Two hypothetical T waves
of the same amplitude have different offset (dashed lines) when the heart
vector becomes perpendicular to the axis of one of the leads. This results in
“real” dispersion of the QT intervals (vertical dashed lines). In addition,
different proportion of the final part of the two T waves is below the
threshold level (e.g., with an automatic threshold method). This leads to
the measured dispersion of the QT intervals (vertical solid line), which is
different from the real dispersion.
Figure 1. Effect of the shape of the T loop on the QT interval measure-
ment in a hypothetical lead. Projections of T loops with different shapes
and at different angles to the axis of the lead result in T waves with different
amplitude and morphology. Only an insignificant proportion of the final
part of a T wave with high amplitude may be unmeasurable because of
falling into the noise band (A); T waves with smaller amplitude as a result
of wider T loop (C) or elongated loop at different angle (B), have a greater
proportion of their final parts falling into the noise band. Thus, the
measurable QT interval can almost coincide with the real end of repolar-
ization (A), or be significantly smaller (B,C). Points 1, 2 and 3 indicate
three time instants of the T loop and of the T wave. (Reproduced with
permission from Kors et al. QT dispersion as an attribute of T-Loop
morphology. Circulation 1999;99:458–63.)
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all repolarization signals originating from repolarization of
ventricular myocardium should belong to the T wave. In
this sense, we agree that the concept of biphasic and other
unusually shaped T waves is more appropriate than a
distinction between the T wave and an augmented U wave
which may lead to serious underestimation of QT interval.
A pattern resembling a U wave may also originate from
slow afterdepolarization of ventricular myocytes. Distinc-
tion of such a pattern from bizarre T waves may be very
difficult. At the same time, in practical QT interval mea-
surements (e.g., for the assessment of acquired long-QT
syndrome) signs of afterdepolarizations indicate the same
proarrhythmic danger as bizarre T wave shapes and pro-
longed QT interval.
Thus, in all cases that are difficult to reconcile, augmented
U waves should be preferably included into the T wave.
Only distinction between T wave and clearly physiologic U
waves of small amplitude should be attempted when mea-
suring QT interval.
Already in 1952, Lepeschkin and Surawicz (27) described
and classified various patterns of T and U wave merging and
suggested methods for determining the end of the T wave
when “buried” within the U wave. They showed that,
depending on the pattern of T-U wave merging, either the
intersection of the tangent to the downslope steepest point
with the isoelectric line, or the nadir between the T and the
U wave is closer to the “real” T wave end. This article is
clearly more often quoted than read. The tangent method
was proposed merely as “. . . an attempt to determine the
true end of the T wave in cases of partial merging of T and
U . . .” (27), rather than as a universal method for determin-
ing of the end of the T wave.
In a recently published extensive review, Surawicz (28)
summarized the available knowledge that could help distin-
guish normal or abnormal U wave merging with a T wave.
It is remarkable that the author adds nothing to the method
proposed in 1952 for exact determining of the T end in case
of merging of the T wave and the U wave.
JT dispersion. In experimental and clinical studies, Zabel
et al. (8,9) showed that the QT dispersion values reflect
better the dispersion of the recovery times than the action
potential duration. On the other hand, the JT dispersion
reflected better the dispersion of action potential duration
(APD)90. Consequently, some authors suggested the QT
and JT dispersions to be used as separate entities rather than
mutual surrogates (29,30). However, neither the QT dis-
persion nor the JT dispersion reflect directly the dispersion
of the ventricular recovery time or of the action potential
duration. As already discussed, the dispersion of various
Figure 3. Main automatic QT measurement techniques. From top to
bottom: threshold method applied to the original T wave (TH), or to its
differential (DTH), tangent method with a tangent to the steepest point of
the descending limb of the T wave (SI), tangent method with a line
through the T wave peak and the maximum slope point (PSI). (Repro-
duced with permission from McLaughlin NB, et al. Comparison of
automatic QT measurement techniques in the normal 12 lead electrocar-
diogram. Br Heart J 1995;74:84–89).
Figure 4. Effect of the shape of the descending part of the T wave on the
QT interval measured with a tangent method. The two hypothetical T
waves have a common offset (vertical dashed line), but significantly
different shape of the descending part. As a result, a tangent to the steepest
point may significantly underestimate (top panel) or overestimate (bottom
panel) the T wave offset.
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repolarization duration intervals is merely an indirect mea-
sure of general repolarization abnormalities. It is therefore
questionable whether JT dispersion offers any real comple-
ment to the QT dispersion, except possibly in cases of
conduction abnormalities such as bundle branch block.
The Q wave dispersion, although significantly smaller
than the T wave offset dispersion, may also influence QT
dispersion (31,32). Traditional manual measurement, as
well as some computer algorithms, assesses the Q wave
onset separately in each lead (33), whereas other computer
algorithms use a common, lead-independent Q onset
(34,35). This may account for part of the variability between
different algorithms.
Measurement features. Theoretically, an accurate assess-
ment of QT dispersion requires all 12 leads of the ECG to
be recorded simultaneously in order to avoid the effect of
QT dynamicity due to heart rate changes. Therefore,
simultaneous 12-lead recordings have been proposed as a
“gold standard” for QT dispersion measurement. On the
other hand, it is possible that the slow dynamicity of the QT
interval (36) renders QT dispersion measurements based on
simultaneous recording of six or even only three recordings
during ectopic-free sinus rhythm acceptable for practical
purposes. This approach, however, has never been properly
validated.
Influence of heart rate. Many studies, including large
prospective evaluations (37,38) used the so-called corrected
QT dispersion, i.e., the dispersion of the QT intervals
corrected for heart rate by some formula. Although the
application of additive formulae for heart-rate correction,
such as those proposed by Hodges et al. (39) and in the
Framingham Study (40) renders identical values for QT
dispersion and QTc dispersion, this is not true for the
multiplicative formulae, which include the Bazett correc-
tion. Although experimental and clinical data show that the
rate, the rhythmicity and the site of impulse origin can
influence the dispersion of the ventricular recovery times
(41–43), this has never been shown for QT dispersion.
Clinical (44) and experimental (45) studies failed to find
correlation between heart rate and the dispersion of ventric-
ular recovery times measured with MAPs or QT dispersion.
The exact relation between the heart rate and the disper-
sion of recovery times is still an unresolved issue. It is
certain, however, that QT dispersion measured in the
standard 12-lead ECG does not depend on (and therefore
should not be corrected for) the heart period in the same
way as the QT interval. Even more importantly, it has been
demonstrated that the dispersion of the corrected QT
intervals may differ between different clinically defined
groups simply from the application of Bazett formula in the
presence of different heart rates (46).
Meanwhile, many studies, including large prospective
ones such as the Rotterdam (37) and the Strong Heart
Study (38) continue to report statistically significant and
physiologically meaningful differences in the “corrected”
QT dispersion between different clinical groups, somewhat
contributing to the credit of this parameter. The gross
inappropriateness of such approaches should clearly be
recognized, especially because the observation of these
studies that increased QT dispersion (i.e., repolarization
abnormality) predicts adverse outcome in a general popula-
tion seems to be independent of the heart rate correction.
Generally, it is incorrect to apply any heart-rate correc-
tion formula to a parameter, the dependence of which on
heart rate, let alone a mathematical model of such depen-
dence, has never been demonstrated.
Influence of the number of ECG leads and of the ECG
lead system. In addition to the original expression of QT
dispersion as the range of QT interval duration in all
measurable ECG leads, many other measurement possibil-
ities have been proposed. To mitigate the effect of outliers in
the QT interval data, standard deviation of the QT interval
duration in all leads (47) or coefficient of variation (SD of
QT/QT average 3100, the so-called relative QT dispersion
[48]) have been used. However, the range and standard
deviation values have been shown to correlate very closely
(47,49).
The number of measurable leads in the standard ECG
also influences the range of QT interval durations. Some
researchers proposed a correction factor dividing QT inter-
val range by the square root of the number of measurable
ECG leads, leading to the so-called adjusted QT dispersion
(50). Hnatkova et al. (47) showed that this formula results
in a reasonable correction of mean values of QT dispersion
in normal ECGs. However, they also showed that the
individual errors caused by omitting separate leads are very
substantial. Consequently, it is not appropriate to compare
results based on QT interval values measured in ECGs of
very different number of measurable leads.
Many clinical studies have measured QT dispersion only
in the six precordial leads. In addition, other lead combi-
nations, such as the orthogonal XYZ or “quasiorthogonal” I,
aVF or V2 leads, have also been studied. It was reported that
although, as one would expect, QT dispersion is decreased
when a smaller number of leads is used for QT measure-
ment, QT dispersion differences between different patient
groups can still be detected with the three leads (aVF, V1,
V4) that are most likely to contribute to QT dispersion (51):
the limb leads (52), the orthogonal (X,Y,Z) (53,54) or the
quasi-orthogonal leads aVF and V2 (51–53). Clearly, prac-
tically any lead combination may detect abnormalities in the
morphology of the T loop and translate them into increased
values of QT dispersion. On the other hand, the more
projections of the T loop into different leads with different
axes are used, the more sensitive the measurement becomes.
Unfortunately, as already mentioned, none of this directly
translates into an increased regional heterogeneity of recov-
ery times. Therefore there is little point in continuing the
quest for the “perfect lead combination” for QT dispersion
measurement.
Reliability of QT dispersion assessment. Many studies
have shown high inter- and intraobserver variability of
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manually measured QT dispersion. The errors reach the
order of the differences between normal subjects and cardiac
patients. Relative errors of 25–40% of interobserver and
intraobserver variability of manual measurement of QT
dispersion have been reported (27,55), and opposed to
relative errors ,6% for manual measurement of the QT
interval (55). Occasionally, substantially better reproducibil-
ity of manual measurement of QT dispersion has also been
reported, with interobserver variability of 13–18% (56) and
even ,5% (57). Explanations of these discrepancies can
only be very speculative. Because a majority consensus
clearly agrees on poor reproducibility of QT dispersion
measurement, a wishful bias was likely involved in some
reports presenting very low measurement errors.
In addition to the differences in the investigated popula-
tions, the variations of the results can be attributed to
differences in the measurement method (manual measure-
ment with calliper or ruler (58), application of a digitizing
board with or without magnification, on screen measure-
ment with electronic callipers, etc.), the noise level, and the
paper speed at which the ECGs were recorded (20). In a
technical study, Malik and Bradford (59) showed that even
the “gold standard” manual measurement using the digitiz-
ing board, can produce intraobserver variations correspond-
ing to purely error-related QT dispersion .40 ms and
.60 ms, in 20% and 10% of observers, respectively.
The available automatic methods for QT measurement
have not shown a superior reproducibility. For example, Yi
et al. (60) reported that the immediate reproducibility (in
sequentially recorded ECGs) of various QT dispersion
indices measured with a downslope tangent method in
healthy volunteers varied between 16% and 44%. Variations
of computer algorithms for T wave offset determination (61)
include signal processing options, the way in which the
tangent is characterized, the definition of the isoelectric line,
the threshold level, etc. Some software packages offer a great
variety of parameter settings. For instance, one of the
versions of the QT Guard software package by GE Mar-
quette (34) offers .100 programmable options for the T
wave end localization.
Many studies tried to validate automatic algorithms
against manual measurement by experienced ECG readers.
The results were disappointing showing large difference
(21,62–64). Savelieva et al. (63) investigated the agreement
between automatic (downslope tangent) and manual QT
measurement in normal subjects and patients with HCM.
The agreement between the two methods of QT interval
measurement was poor and lower in normal subjects (r2 5
0.10 to 0.25 in the separate leads) than in HCM patients
(r2 5 0.46 to 0.67). The agreement between automatic and
manual measurement of QT dispersion was even much
worse (r2 5 0.06 in HCM patients and r2 5 0.00 in normal
subjects, Fig. 5).
Relatively few studies compared different algorithms for
automatic QT measurement. McLaughlin et al. (61) com-
pared two threshold and two slope-based techniques, and a
validated manual measurement. The results of the mean
measurements with different algorithms varied up to 62 ms,
which was greater than the manual interobserver variability.
The threshold algorithm demonstrated the largest variabil-
ity and its results depended on filtering and algorithm
parameters. In another study (65) the same authors showed
that the variability of automatic QT measurement in cardiac
patients was twice that in normal subjects and that it was
significantly increased with the decrease of the T wave
amplitude. In a study only part of which was published,
Batchvarov et al. (66) evaluated the multiple parameter
options in the QT Guard package. The differences between
the downslope tangent method using different numbers of
samples around the inflex point used for the tangent
computation and the modifications of the threshold method
were substantial. Changes in the permissible range of the
settings of the package led to differences of up to 60 ms in
normal subjects and up to 70 ms in HCM patients. Hence,
only comparison of results obtained with the same auto-
matic methods and with the same parameter setting is
appropriate.
Unfortunately, no systematic experience exists that would
allow an optimum algorithmic setting to be selected. More-
over, it seems reasonable to speculate that all present
algorithmic approaches to QT interval measurement are
too simplistic and superficial and that a truly successful
algorithm for automatic QT interval measurement will
eventually need to be based on a completely different
mathematical approach reflecting a deep electrocardio-
graphic knowledge.
Figure 5. Agreement between automatic and manual measurement of QT
dispersion in patients with hypertrophic cardiomyopathy. The differences
between the measurements are plotted against the mean value from the two
measurements. Most of the differences are within 2 SD from the mean
differences (dashed line), which is approximately 660 ms, obviously an
unacceptably high measurement error. There is also no correlation between
the two sets of measurements (r2 5 0.00). (Reproduced with permission
from Savelieva I, et al. Agreement and reproducibility of automatic versus
manual measurement of QT interval and QT dispersion. Am J Cardiol
1998;81:471–7).
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CLINICAL STUDIES
A review of the extreme abundance of studies on QT
dispersion published over the past decade reveals an amaz-
ingly wide range of QT dispersion values in both “positive”
and “negative” studies, and a complete lack of any tendency
towards establishing reference values. For example, large
studies (67) or literature reviews (68) suggesting QT dis-
persion of 65 ms as an upper normal limit in healthy subjects
were published alongside reports claiming QT dispersion
.40 ms to have 88% sensitivity and 57% specificity for
prediction of inducibility of sustained ventricular tachycar-
dia during an electrophysiology study (69). Many of the
studies with positive results published QT dispersion data
well within the demonstrated measurement error of both
manual and automatic measurement.
QT dispersion in normal subjects and in the general
population. Literature reviews found the QT dispersion to
vary mostly between 30 and 60 ms in normal subjects
(70,71), although average values around 70 ms were also
reported. In 51 studies (40 published during the past three
years) in which QT dispersion was measured in 56 groups
with a total of 8,455 healthy subjects of various ages
(including three large studies of healthy children [72–74]),
we found mean QT dispersion values (QT maximum–QT
minimum) to range from 10.5 6 10.0 ms (75) to 71 6 7 ms
(76). The weighted mean 6 SD from all these studies is
33.4 6 20.3 ms (Fig. 6), while the median is 37 ms.
Moreover, most researchers reported a wide overlap of
values between normal individuals and different patient
groups (Figs. 6 and 7). Thus, all values proposed for upper
normal limit in healthy subjects are unreliable.
Published reports show either no statistically significant
difference in QT dispersion between the genders (11,73) or
marginally greater values in men (77,78). Age-related dif-
ferences ,10 ms were reported and appeared to be statis-
tically significant in some studies (79,80) but not in others
(72,73). For example, in the study by Savelieva et al. (81) on
more than 1,000 healthy subjects, QT dispersion was
29.1 6 17.8 ms in the age group of 17 to 29 years and
21.7 6 13.3 ms in the age group of 50 to 80 years (p ,
0.0001). However, in another large study, Macfarlane et al.
(11) found no significant age differences (QT dispersion of
23.6 67.7 ms, 24.8 6 8.2 ms, 24.8 6 8.5 ms and 24.5 6
9.8 ms in the age groups of ,30, 30–40, 40–50 and .50
years, respectively). In this study, no age differences of QT
dispersion were found in 1,784 neonates, infants and chil-
dren divided in 16 age groups from ,24 h to .15 years of
age.
Several large prospective studies published recently as-
sessed the predictive value of QT dispersion for cardiac and
all-cause mortality in the general population. In the Rot-
terdam study (37) QT dispersion was found to predict
cardiac mortality in a general population of 5,812 adults of
55 years or older, followed up for 3 to 6.5 (mean 4) years.
In the Strong Heart Study (38) the predictive value of the
“corrected” QTc dispersion was assessed in 1,839 American
Indians followed up for 3.7 6 0.9 years. Heart rate corrected
QT interval assessed as a continuous variable remained a
significant and independent predictor of cardiovascular
Figure 6. Weighted mean 6 SD values of QT dispersion (in milliseconds) from reviewed studies in normal subjects, patients with chronic myocardial
infarction (chr.MI), left ventricular hypertrophy (LVH) of various etiology except hypertrophic cardiomyopathy, in heart failure and dilated cardiomyopathy
(HF,DCM), in hypertrophic cardiomyopathy (HCM), in acute myocardial infarction (acute MI), and in long-QT syndrome (LQTS). See text for details.
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mortality in both univariate and multivariate Cox Propor-
tional Hazard Models, with 34% increase of cardiovascular
mortality for each 17 ms increase in QTc dispersion in
multivariate analysis. In multivariate analysis QTc disper-
sion .58 ms (the upper 95th percentile in a separate
population of normal subjects) was associated with a 3.2-
fold increased risk of cardiovascular mortality (95% confi-
dence interval [CI] 1.8–5.7). Unfortunately, no values for
the uncorrected QT dispersion or the simple resting heart
rate were provided. Thus, the possibility of the strong
predictive power being maintained by the differences in
heart rate cannot be excluded.
The West of Scotland Coronary Prevention Study
(WOSCOPS) (82) included 6,595 middle-aged men with
moderately raised cholesterol but no previous MI. In a
multivariate analysis, an increment of 10 ms in QT disper-
sion increased risk for death of coronary heart disease or
nonfatal MI by 13% (95% CI 4% to 22%, p 5 0.0041). QT
dispersion .44 ms carried an increased risk of 36% (95% CI
2% to 81%, p 5 0.034) compared with QT dispersion
,44 ms. On the other hand, this cutoff level of 44 ms had
a sensitivity of only 8.8% with a specificity of 93.8%. The
area under the receiver operator characteristic curve was only
54%, indicating an almost complete lack of predictive power
of QT dispersion.
QT dispersion in cardiac disease. A majority of studies
have shown increased QT dispersion in various cardiac
diseases. We have pooled data from 18 studies with a total
of 2,525 post-MI patients; 16 studies with 855 patients with
LVH of various origin, excluding HCM; 8 studies with
1,082 patients with heart failure, including idiopathic
DCM; 11 studies with 635 patients with HCM; 16 studies
with a total of 1,578 patients with acute MI; and 10 studies
with 208 patients with long-QT syndrome of various
genotype (Fig. 6).
There is a clear tendency towards increase of QT disper-
sion in various cardiac diseases, with highest mean values
reported in long-QT syndrome, “the pure global repolar-
ization disease” (Figs. 6 and 7). On the other hand, the
overlap of values between patients with different cardiac
diseases, between patients and normal subjects, and the wide
variation of values within each cardiac disease render any
attempt at establishing reference values fruitless. However,
patients with various clinical symptoms, with and without
arrhythmias, and on various medications have been included
in these pooled studies, which probably accounts for part of
the variation.
Generally, QT dispersion is increased in acute MI,
although mean values from 40 6 18 (75) to 162.3 6
64.8 ms (83) have been reported. Although QT dispersion
is increased in the chronic phase of MI and in other chronic
forms of ischemic artery disease, there seems to be a trend
towards lower values compared with the acute phase of MI,
possibly due to the spontaneous dynamicity or to revascu-
larization procedures. Some authors did not find significant
differences in QT dispersion between patients with chronic
MI or other forms of chronic CAD and normal subjects
(84,85).
Figure 7. Mean6SD of QT dispersion (in milliseconds) from the reviewed studies of normal subjects, and patients with chronic myocardial infarction, left
ventricular hypertrophy, heart failure and dilated cardiomyopathy, hypertrophic cardiomyopathy, acute myocardial infarction, and long QT syndrome.
Abbreviations as in Figure 6. See text for details.
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Compared with healthy controls, an increased QT dis-
persion has been reported in heart failure and left ventricular
dysfunction of various etiology (86–89) including highly
trained athletes (90–92), in LVH of various origin (93–97),
in patients with arterial hypertension irrespective of the
presence or absence of hypertrophy (98), in HCM patients
compared with healthy controls (99–101), in long-QT
syndrome (102–104) and in many other cardiac and even
noncardiac diseases. However, some studies have found QT
dispersion values not significantly different between healthy
subjects and patients with heart failure (105), patients with
LVH as a result of physical training (106–108), or between
patients with and without LVH (109).
Many studies tried to correlate QT dispersion with the
extent or the localization of the pathological process of
various diseases. Some studies have shown greater QT
dispersion in anterior compared to inferior MI (110–112);
correlation between QT dispersion in MI and indirect
measures of infarct size, such as ejection fraction (113); or
the amount of viable myocardium in the infarct region
(114). Similarly, significant correlation between QT disper-
sion and left ventricular mass index in hypertensive patients
with LVH was found in some studies (115,116), but not in
others (117).
Changes of QT dispersion have been shown to follow the
spontaneous or induced dynamicity of the pathological
process in some cardiac diseases. For instance, QT disper-
sion seems to undergo dynamic changes during the first day
(118), as well as during the following days (119,120), of
acute MI. It increases significantly during ischemia induced
by balloon inflation during angioplasty (121–123), by exer-
cise stress testing (124) or atrial pacing (125), or during
reperfusion following angioplasty (126). It has also been
shown to correlate with improvement of left ventricular
contractility on the echocardiogram after infarction (127)
and with the degree of improvement of left ventricular
function after revascularization (128,129).
Treatment has been shown to decrease QT dispersion,
e.g., after successful reperfusion after thrombolysis
(130,131), revascularization with angioplasty (132–134) or
coronary artery bypass grafting (129). Treatment of patients
with heart failure with losartan (135), successful antihyper-
tensive treatment of patients who had hypertension with
LVH (136–139), or successful beta-blocker treatment of
patients with long-QT syndrome (140) have also been
shown to decrease QT dispersion.
Prognostic value of QT dispersion. Many studies have
been aimed at investigating the value of QT dispersion for
the prediction of ventricular arrhythmias or other adverse
events in various cardiac diseases. The results are again
controversial.
We have pooled data from 23 studies on patients with
and without serious ventricular arrhythmias in various car-
diac diseases, most of them with ischemic heart disease.
Altogether, 490 patients with and 1,341 patients without
serious ventricular arrhythmias were included. Although
most studies show significantly greater QT dispersion in
patients with arrhythmias, the values largely overlap (Fig.
8).
Several studies, most of them retrospective, have found
that patients with acute (141,142) or chronic MI (143–145)
with ventricular arrhythmias have significantly higher QT
dispersion than patients without arrhythmias. However, the
first prospectively analyzed study in post-MI patients re-
ported by Zabel et al. (146) showed that none of the 26
ventricular dispersion indices that were tested had any
predictive value for an adverse outcome in 280 consecutive
MI survivors followed up for 32 6 10 months. Newer
studies (147,148) provided controversial findings. The main
prospective studies on QT dispersion are summarized in
Table 1.
Some studies showed that QT dispersion could predict
inducibility of ventricular arrhythmias during electrophysi-
ology study (149–151), whereas others failed to observe this
(152–154).
Several studies (155–157) showed significant correlation
between QT dispersion and outcome in patients with heart
failure. Analysis (158) from the ELITE heart failure study,
in which heart failure patients treated with the
angiotensin-II antagonist losartan had reduction of sudden
cardiac death compared with those treated with captopril
(159), showed that captopril but not losartan increased QT
dispersion. However, the results of ELITE were not con-
firmed by the much larger double-blind, randomized con-
trolled ELITE-II trial (160), in which patients treated with
losartan showed no significant differences in all-cause mor-
tality, sudden death or resuscitated cardiac arrest compared
with those treated with captopril. The analysis of the ECG
data of ELITE-II will shed additional light on the value of
repolarization assessment in patients with heart failure.
Substudies of the DAMOND-CHF Study (161), the
UK-HEART study (162) as well as other large prospective
studies (163) failed to show any power of QT dispersion for
predicting outcome in heart failure patients. Available
studies also failed to show independent predictive value of
QT dispersion for sudden cardiac death and cardiac mor-
tality in patients with LVH (164).
Several authors reported significantly higher QT disper-
sion in HCM patients with ventricular arrhythmias com-
pared with those without arrhythmias (165–167). Larger
studies, however, did not confirm these findings (168,169).
In long-QT syndrome, the diagnostic value of increased
QT dispersion seems undisputed. On the other hand,
although Priori et al. (170) reported that patients not
responding to beta-blockers had a significantly higher QT
dispersion than responders (137 6 52 vs. 75 6 38 ms, p ,
0.05), no other presently available data suggest that QT
dispersion has any prognostic value in patients with
long-QT syndrome.
Generally, the positive results of small retrospective
studies conducted in the years of initial enthusiasm were
later confirmed only in some very large prospective studies.
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However, even in the large studies, patient groups with
adverse outcomes often had QT dispersion values well
within both the measurement error and the range of values
in healthy subjects reported in other studies. Thus, as
phrased by Surawicz (171), the positive results can be
interpreted as indicating an “indifferent” QT dispersion.
This does not necessarily signify lack of clinical importance.
In the majority of the cases, the abnormality was already
visible from abnormal T wave morphology and/or increased
QT interval. At present, this does not necessitate a specific
therapeutic action and, in practice, does not help in the risk
stratification of individual patients.
Effect of drugs on QT dispersion and the risk of torsades
de pointes tachycardia. The limitations of both the pres-
ence and the degree of QT interval prolongation for
prediction of torsades de pointes are well known (172).
Consequently, the potential role of QT dispersion for the
prediction of drug-induced torsades de pointes has been
addressed in several studies.
Quinidine increases QT dispersion (173,174) and, unlike
the corrected QTc interval, increased QT dispersion seems
to have some predictive value for development of torsades de
pointes during quinidine therapy (173,174). Sotalol has
been shown to decrease (175) or not to change (176) QT
dispersion in patients with ischemic heart disease. However,
Dancey et al. (177) observed increased QT dispersion in 4
cases of torsades de pointes caused by low dose sotalol in
patients with renal failure.
In clinical studies, amiodarone has been reported to
decrease (176,178) or not to change (173,179,180) QT
dispersion. It is known that amiodarone can be administered
relatively safely in patients who had experienced torsades de
pointes during antiarrhythmic therapy with other drugs
(181) and this effect is paralleled by a decrease of QT
dispersion (173). However, cases of an excessive increase of
QT dispersion and induction of torsades de pointes by
amiodarone have also been reported (182). On the other
hand, it has been demonstrated that increase of QTc and
QT dispersion during chronic amiodarone treatment does
not affect survival and is independent of the decrease in
arrhythmia risk (183).
Propafenone (184), disopyramide (185) and almokalant
(blocker of the rapid component of the delayed rectifier, IKr)
(186) has been shown to increase QT dispersion, whereas in
one study dofetilide infusion did not produce increase of the
dispersion of repolarization between two right ventricular
endocardial sites (187). A decrease of QT dispersion after
treatment with azimilide (188) and magnesium has also
been reported (189).
In addition to long-QT syndrome (140), beta-blockers
have been shown to decrease QT dispersion in patients with
syndrome X (190) and heart failure (191), but not in HCM
(168).
Figure 8. Mean and standard deviations of QT dispersion in patients with (closed circles) and without (open circles) serious ventricular arrhythmias. In
one study patients with ventricular fibrillation (closed diamond) and sustained monomorphic ventricular tachycardias (closed circle) were compared
separately with patients without sustained ventricular arrhythmias. *p , 0.05 between groups with and without serious ventricular arrhythmias; NS:
statistically nonsignificant difference between groups with and without serious ventricular arrhythmias.
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It seems that ECG monitoring of the effect of drugs that
prolong ventricular repolarization is the only area in which
QT dispersion preserved (some) immediate clinical signifi-
cance. Grossly abnormal values (e.g., $100 ms, unlikely to
be due to measurement error) during treatment with drugs
effecting repolarization signify “bad QT dispersion” (171),
which probably should prompt urgent assessment of the
drug effect. On the other hand, lack of abnormal QT
dispersion value is by no means a reassuring sign of
therapeutic safety. Generally, the ECG detection of in-
creased risk of torsades de pointes during treatment with
repolarization-active drugs is still an unresolved issue, and
most probably QT dispersion will have only some support-
ive value even in this area.
CONCLUSIONS
QT dispersion after 10 years. Contrary to the initial
expectations, QT dispersion did not evolve into a useful
clinical tool. Although this simple ECG parameter is
probably not (only) a result of measurement error, it does
not reflect directly and in a quantifiable way the dispersion
and the heterogeneity of the ventricular recovery times. The
standard 12-lead ECG contains information about regional
electrical phenomena, but this information cannot be ex-
tracted by such a simple technique as QT dispersion
assessment.
In addition, not only the magnitude of dispersion of
recovery times, but the distance over which they are dis-
persed is important for arrhythmogenesis. In a similar way
as we distinguish, though arbitrarily, “micro reentry” from
“macro reentry,” it seems logical to distinguish dispersion of
recovery times of adjacent areas (local dispersion) from
dispersion over large areas (global dispersion) and, possibly,
from dispersion between both ventricles (interventricular
dispersion). Such a scale is clearly beyond the resolution of
the standard surface ECG. Local dispersion of recovery
times created by MI is no more visible on the standard
surface ECG than the delayed conduction caused by the
same infarct.
The very idea of detecting and quantifying only the
dispersion of the end of repolarization, i.e., the dispersion of
the complete recovery times, also seems questionable. Ac-
tion potentials of different duration usually have very dif-
ferent shape, particularly during phase 3. Such a “phase 3
dispersion,” i.e., the dispersion of the partial recovery times,
has direct relation to arrhythmogenesis. Although it is
reflected in the shape of the T wave, it does not contribute
to the dispersion of the ends of the MAPs, let alone the
dispersion of the QT intervals.
In a recently published experimental study Shimizu et al.
(192) showed that the T wave alternans induced by rapid
pacing were a result of alterations in the APD of the
M-cells, leading to exaggeration of transmural dispersion of
repolarization during alternate beats, and thus to the poten-
tial for development of torsades de pointes. The result of the
study clearly emphasized that spatial dispersion of the
recovery times cannot be estimated without the analysis of
the morphology of the T wave, as well as without taking
into account its dynamicity.
“State of the art” of QT dispersion. Despite all limita-
tions, the decade of investigation of QT dispersion empha-
sized the clinical importance of the repolarization abnor-
malities. We have to understand that QT dispersion is
nothing more (and nothing less) than an approximate and
simplistic expression of repolarization abnormality. The
concept of QT dispersion seems to be a correct step,
although a small step, in the correct direction. In the
absence of other widespread possibility of quantifying repo-
larization abnormality in 12-lead ECGs it is probably not
that unreasonable to use QT dispersion in approximate pilot
studies. Because it seems reasonable to speculate that there
is a monotonic relationship between measured values of QT
dispersion and the degree of repolarization abnormality (i.e.,
that greater values of QT dispersion indicate greater repo-
larization pathology), it is not even very unreasonable to
subject the numerical measurements of QT dispersion to
statistical tests.
At the same time, the technology clearly suffers from
serious methodological problems, from the lack of any direct
link to a pathophysiological background, and from complete
absence of any reference values. At present, the role of QT
dispersion (if any) should therefore be restricted purely to
preliminary pilot investigations when testing hypotheses of
whether changes in myocardial repolarization are involved
in a given pathology, condition or clinical prognosis. When
such pilot studies are attempted, all limitations of the
technology must be recognized and accounted for. Strictly
blinded evaluation of measured ECGs is essential because
difficulties of QT interval measurement in tracings with
abnormal T waves are likely to contribute to increased QT
dispersion. Because the measurement is also poorly repro-
ducible, all ECGs of any study must be read by two or
perhaps even more independent experienced electrocardio-
logists.
The technological limitations and methodological prob-
lems also impose serious restrictions on the interpretation of
the results of any study, including those already published.
The poor reproducibility and substantial dependence of the
measurement on the operator make the results of different
studies not easily comparable. Group differences of only few
milliseconds even when statistically significant, should al-
ways be interpreted with caution and skepticism because
they are unlikely to be reproducible. Similarly, the lack of a
difference in QT dispersion values does not prove the
absence of the involvement of myocardial repolarization.
The technology is clearly too crude to depict minor repo-
larization changes.
When evaluating clinical studies, “approximate repolar-
ization characteristics” should always be read in place of QT
dispersion. Hence, the clinical studies reviewed in the
previous section show that disturbed ventricular repolariza-
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tion is linked to poor prognosis in a general population, is
present in survivors of acute MI, etc. At the same time, the
particular numerical values of QT dispersion reported in
individual studies are of little consequence.
In clinical practice concerning individual patients, only
grossly abnormal values of QT dispersion that are clearly
outside the possible measurement error, e.g., $100 ms, may
have a significance by signaling that the repolarization is
abnormal. It seems, therefore, that the potential clinical use
will be limited to diseases and syndromes in which such
values may be encountered, e.g., drug-induced torsades de
pointes. Of course, one can wonder about the likelihood of
finding such extreme values in ECGs with normal T wave
morphology and how likely is QT dispersion to offer any
additional information beyond the traditional verbal diag-
nosis of substantial T wave abnormality. Even in long-QT
syndrome, i.e., in the case of the pure global repolarization
disease, QT dispersion failed to add substantial additional
information to that provided by the general observation of
abnormal TU complexes.
The major technical problem of QT dispersion is the
imprecision of T wave end localization. Further purifica-
tions of technology of QT dispersion, such as optimum lead
selection, replacement of the simple computation of the
range of QT interval durations, various correction factors,
etc., are clearly unable to overcome this principal shortcom-
ing of the concept of QT dispersion and should therefore be
discouraged. We should also discourage evaluations of QT
dispersion in studies of a small number of ECGs because
they are unlikely to contribute to our understanding of
physiological and clinical correlates of repolarization
changes. Perhaps QT dispersion may only have a role in
evaluating very large collections of ECGs when the simplic-
ity and speed with which QT dispersion can be measured
may have some practical appeal. In such cases, all the
limitations and restrictions of the technology and concept of
QT dispersion must always be remembered. Actually, many
would probably second the view that the most “state-of-the-
art” approach to QT dispersion assessment is not to perform
it at all.
Where Do We Go From Here?
As Abildskov et al. (193) wrote 13 years ago , the regional
information continues to be a part of “The Unidentified
Information Content of the Electrocardiogram.”
Classification and quantification of the regional informa-
tion in the 12-lead ECG remains a challenging problem.
Despite initial hopes, it is now obvious that it has not been
addressed by QT dispersion, which is more about global
than localized repolarization abnormality.
Older concepts of quantification of repolarization abnor-
malities, as well as newer ideas, deserve more attention than
parameters based on duration of repolarization intervals.
Principal component analysis has been used for decades in
the analysis of ECG signals from body surface potential
mapping for reduction of redundancy of the data (194).
Recently, principal component analysis has also been im-
plemented to assess the complexity of the T wave from
standard 12-lead ECG and from 12-lead digital Holter
recordings. The method has been shown to differentiate
between normal subjects and patients with long-QT syn-
drome from 12-lead Holter ECGs (195) and in patients
with HCM (196) and arrhythmogenic right ventricular
dysplasia (197). In general (1,194), the method defines the
principal, nonredundant spatial components (or “factors”)
into which the T wave is decomposed and that contribute
(in descending order of significance) to the morphology of
the T wave. The significance of each component is mea-
sured by its eigenvalue. When the repolarization is uniform,
i.e., the T wave is smooth, without notches, most of the
information about its morphology is contained in the first,
main principal component. When the T wave becomes
more complex, the relative value of the next, smaller
components of the T wave increases (i.e., their eigenvalues
increase). Although principal component analysis has al-
ready been included in some commercially available pro-
grams for automatic repolarization analysis, its clinical role
is still not well defined.
Frontal and horizontal T wave axis has also been dem-
onstrated to be predictive of cardiac mortality (198). Most
probably, other wavefront direction parameters based on
measurement of vector time integrals (i.e., QRST areas) will
also be studied in the near future.
Most recently, a concept of measuring the T wave
“morphology dispersion” in surface ECGs has been pro-
posed by Acar et al. (199). Based on single-value decom-
position of simultaneously recorded 12-lead ECGs and on
the computation of the eigenvalues of the signal, they
proposed several indices characterizing the sequence of
repolarization changes through the ventricular myocardium,
including parameters describing the dissimilarities of the
shape of the T wave in individual ECG leads. Comparison
of normal and abnormal ECG of HCM patients showed
that indices of T wave morphology separated these two
groups more powerfully than both QT dispersion and
rate-corrected QT interval duration. The concept was sub-
sequently applied to the ECGs database of the first pro-
spective study on QT dispersion in survivors of MI by Zabel
et al. (146). They showed that unlike QT dispersion,
selected indices of T wave morphology characteristics ob-
tained from single-beat resting 12-lead ECGs are powerful
and independent predictors of adverse events during
follow-up (17).
Only after more experience has accumulated with these
and other descriptors of repolarization morphology will it be
possible to address their relationship to the expressions of
repolarization dynamicity, such as T wave alternans or
QT/RR relationship and adaptation. The present ap-
proaches to the assessment of repolarization dynamics are
also rather simplistic and in need of further improvement.
Studies of the dynamics of repolarization morphology are an
obvious step forward. It is therefore reasonable to expect
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that the distinction between “static” and “dynamic” repolar-
ization assessment will gradually be suppressed and that a
“comprehensive” spectrum of repolarization characteristics
will eventually appear.
Future efforts should concentrate on more focused and
more detailed technologies for repolarization assessment.
The available technologies (e.g., principal component anal-
ysis, T wave loop descriptors, T wave morphology disper-
sion) should be subjected to evaluation in existing ECG
databases and in ECG collections of new studies. At the
same time, special effort should be devoted to the develop-
ment of new ECG processing concepts addressing detailed
aspects of repolarization characteristics and repolarization
changes.
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